Literature DB >> 26105955

Deciphering the Epigenetic Code of Cardiac Myocyte Transcription.

Sebastian Preissl1, Martin Schwaderer1, Alexandra Raulf1, Michael Hesse1, Björn A Grüning1, Claudia Köbele1, Rolf Backofen1, Bernd K Fleischmann1, Lutz Hein2, Ralf Gilsbach2.   

Abstract

RATIONALE: Epigenetic mechanisms are crucial for cell identity and transcriptional control. The heart consists of different cell types, including cardiac myocytes, endothelial cells, fibroblasts, and others. Therefore, cell type-specific analysis is needed to gain mechanistic insight into the regulation of gene expression in cardiac myocytes. Although cytosolic mRNA represents steady-state levels, nuclear mRNA more closely reflects transcriptional activity. To unravel epigenetic mechanisms of transcriptional control, cell type-specific analysis of nuclear mRNA and epigenetic modifications is crucial.
OBJECTIVE: The aim was to purify cardiac myocyte nuclei from hearts of different species by magnetic- or fluorescent-assisted sorting and to determine the nuclear and cellular RNA expression profiles and epigenetic marks in a cardiac myocyte-specific manner. METHODS AND
RESULTS: Frozen cardiac tissue samples were used to isolate cardiac myocyte nuclei. High sorting purity was confirmed for cardiac myocyte nuclei isolated from mice, rats, and humans. Deep sequencing of nuclear RNA revealed a major fraction of nascent, unspliced RNA in contrast to results obtained from purified cardiac myocytes. Cardiac myocyte nuclear and cellular RNA expression profiles showed differences, especially for metabolic genes. Genome-wide maps of the transcriptional elongation mark H3K36me3 were generated by chromatin-immunoprecipitation. Transcriptome and epigenetic data confirmed the high degree of cardiac myocyte-specificity of our protocol. An integrative analysis of nuclear mRNA and histone mark occurrence indicated a major impact of the chromatin state on transcriptional activity in cardiac myocytes.
CONCLUSIONS: This study establishes cardiac myocyte-specific sorting of nuclei as a universal method to investigate epigenetic and transcriptional processes in cardiac myocytes of different origins. These data sets provide novel insight into cardiac myocyte transcription.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cardiac myocyte; epigenetics; histone modifications; nuclear RNA; transcriptome

Mesh:

Year:  2015        PMID: 26105955     DOI: 10.1161/CIRCRESAHA.115.306337

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  33 in total

1.  YAP Partially Reprograms Chromatin Accessibility to Directly Induce Adult Cardiogenesis In Vivo.

Authors:  Tanner O Monroe; Matthew C Hill; Yuka Morikawa; John P Leach; Todd Heallen; Shuyi Cao; Peter H L Krijger; Wouter de Laat; Xander H T Wehrens; George G Rodney; James F Martin
Journal:  Dev Cell       Date:  2019-02-14       Impact factor: 12.270

2.  Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.

Authors:  Sirisha M Cheedipudi; Scot J Matkovich; Cristian Coarfa; Xin Hu; Matthew J Robertson; Mary Sweet; Matthew Taylor; Luisa Mestroni; Joseph Cleveland; James T Willerson; Priyatansh Gurha; Ali J Marian
Journal:  Circ Res       Date:  2019-04-12       Impact factor: 17.367

3.  Revisiting Preadolescent Cardiomyocyte Proliferation in Mice.

Authors:  Maretoshi Hirai; Paola Cattaneo; Ju Chen; Sylvia M Evans
Journal:  Circ Res       Date:  2016-03-18       Impact factor: 17.367

4.  Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development.

Authors:  Benjamin R Nixon; Alexandra F Williams; Michael S Glennon; Alejandro E de Feria; Sara C Sebag; H Scott Baldwin; Jason R Becker
Journal:  JCI Insight       Date:  2017-02-23

5.  T-box transcription factor 3 governs a transcriptional program for the function of the mouse atrioventricular conduction system.

Authors:  Rajiv A Mohan; Fernanda M Bosada; Jan H van Weerd; Karel van Duijvenboden; Jianan Wang; Mathilda T M Mommersteeg; Ingeborg B Hooijkaas; Vincent Wakker; Corrie de Gier-de Vries; Ruben Coronel; Gerard J J Boink; Jeroen Bakkers; Phil Barnett; Bas J Boukens; Vincent M Christoffels
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-16       Impact factor: 11.205

6.  BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C-deficient mice.

Authors:  Gaelle Auguste; Leila Rouhi; Scot J Matkovich; Cristian Coarfa; Matthew J Robertson; Grazyna Czernuszewicz; Priyatansh Gurha; Ali J Marian
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808

7.  Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA.

Authors:  Matthew S Stratton; Charles Y Lin; Priti Anand; Philip D Tatman; Bradley S Ferguson; Sean T Wickers; Amrut V Ambardekar; Carmen C Sucharov; James E Bradner; Saptarsi M Haldar; Timothy A McKinsey
Journal:  Cell Rep       Date:  2016-07-14       Impact factor: 9.423

8.  FTO-Dependent N6-Methyladenosine Regulates Cardiac Function During Remodeling and Repair.

Authors:  Prabhu Mathiyalagan; Marta Adamiak; Joshua Mayourian; Yassine Sassi; Yaxuan Liang; Neha Agarwal; Divya Jha; Shihong Zhang; Erik Kohlbrenner; Elena Chepurko; Jiqiu Chen; Maria G Trivieri; Rajvir Singh; Rihab Bouchareb; Kenneth Fish; Kiyotake Ishikawa; Djamel Lebeche; Roger J Hajjar; Susmita Sahoo
Journal:  Circulation       Date:  2019-01-22       Impact factor: 29.690

9.  Peering Into the Cardiomyocyte Nuclear Epigenetic State.

Authors:  Caitlin C O'Meara; Richard T Lee
Journal:  Circ Res       Date:  2015-08-14       Impact factor: 23.213

10.  Haploinsufficiency of Tmem43 in cardiac myocytes activates the DNA damage response pathway leading to a late-onset senescence-associated pro-fibrotic cardiomyopathy.

Authors:  Leila Rouhi; Sirisha M Cheedipudi; Suet Nee Chen; Siyang Fan; Raffaella Lombardi; Xiaofan Chen; Cristian Coarfa; Matthew J Robertson; Priyatansh Gurha; Ali J Marian
Journal:  Cardiovasc Res       Date:  2021-09-28       Impact factor: 13.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.